ArticleHeliyon2024

HDAC6 inhibitor ACY-1215 protects from nonalcoholic fatty liver disease via inhibiting CD14/TLR4/MyD88/MAPK/NFκB signal pathway.

Shifeng Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.